Bertrand Damour has 20 years’ international management experience and a successful track record across the biotech industry in Europe and US. He was previously CEO at the US proteomics company GeneProt Inc.; Mind NRG, a Swiss biotech in the field of CNS (which was acquired by Minerva Neurosciences (NASDAQ: NERV); OncoEthix, a Swiss based oncolog...
Roles at NBE Therapeutics
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at NBE Therapeutics
My pet peeves
My communication style